Dr. Nigel Key and Dr. Anna Falanga join us for a conversation on the updated ASCO VTE prophylaxis and treatment in patients with cancer guideline. They discuss recent evidence assessing apixaban for ...
The earliest published study on this topic was a retrospective case–control study by Northup and associates [8] focusing on 113 inpatients with cirrhosis who had newly diagnosed VTE during hospital ...
"We still have a lot of work ahead to define what the most informative prediction/scoring VTE systems are, for both newly diagnosed and relapsed/refractory MM patients, and how we can make them more ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
Once-daily venous thromboembolism (VTE) prophylaxis with 10 mg of rivaroxaban for either 7 or 28 days after bariatric surgery was found to be effective and safe. Venous thromboembolism (VTE) is known ...
Venous thromboembolisms are the leading cause of preventable hospital death, underscoring the need for clinical leaders to build a strong prevention program. During a March 24 webinar hosted by Becker ...
(HealthDay News) — Provider-level dashboard and pay-for-performance programs may increase compliance with venous thromboembolism (VTE) prevention measures, according to research published online ...
No increased delirium with hydromorphone after hip surgery Aspirin for 28 days is non-inferior to and as safe as dalteparin for preventing venous thromboembolism. HealthDay News — Twenty-eight days of ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients who received either aspirin or enoxaparin for ...
Am J Health Syst Pharm. 2012;69(8):658-663. There are inherent limitations to the determination of VTE risk in the population of patients with cirrhosis. In most of the studies evaluated in this ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results